Congratulations, Henry!
Our poster, Henry L Niman, had his blog linked to Instapundit today. That resulted in an "Instalanche," I am sure. Here is Frank Reynold's link, Henry's post that caused the link, and Henry's BG from his blog. I am delighted to have such a distinguished poster in our midst.
MORE WARNINGS ABOUT AVIAN FLU: I still hope this will be an overrated threat, but I'm pretty worried.
instapundit.com
Commentary
recombinomics.com
Thai Binh Haiphong and Quang Ninh H5N1 Clusters
Recombinomics Commentary
April 6, 2005
The clusters of bird flu in northern Vietnam have merged and now cover the northeastern coastline of Vietnam adjacent to Haiphong Harbor.
The three provinces, Thai Binh, Haiphong, and Quang Ninh have the three largest clusters in terms of members admitted on the same day (Haiphong), longest transmission chain including two health care workers (Thai Binh), and first heath care worker fatality (Quang Ninh).
There is clear human-to-human transmission going on in this region, which led to the executive order on April 1 in the US authorizing bird flu quarantine.
Quang Ninh is adjacent to China, and the four cases at the Vietnam-Sweden hospital are ringing alarm bells loudly.
The flu pandemic of 2005 has clearly begun.
Founder
Recombinomics, Inc. Founder and President, Henry L Niman earned a PhD at the University of Southern California in 1978. His dissertation focused on feline retroviral expression in tumors in domestic cats.
He took a postdoctoral position at Scripps Clinic and Research Foundation where he developed monoclonal antibody technology. He fused monoclonal antibody and synthetic peptide technologies and accepted a staff position at Scripps.
In 1982, he developed the flu monoclonal antibody, which is widely used throughout the pharmaceutical, biotech, and research industries in epitope tagging techniques. He also produced a broad panel of monoclonal antibodies against synthetic peptides of oncogenes and growth factors. These monoclonal antibodies were distributed worldwide to researchers by the National Cancer Institute. The antibodies identified novel related proteins which correlated with clinical parameters.
This technology was used to form ProgenX, a cancer diagnostic company that became Ligand Pharmaceuticals. Dr Niman subsequently identified protein expression patterns at the University of Pittsburgh. More recently, he became interested in infectious diseases while at Harvard Medical School. He then founded Recombinomics and discovered how viruses rapidly evolve. These latest findings are the subject of recent patent filings. |
